Adaptive Immune Regulation of Traumatic Injury
Adaptive Immune Regulation of Traumatic Injury
批准号:
10186694
负责人:
JAMES A. LEDERER
金额:
$41.46万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-10 至 2025-05-31
关键词:
AcuteAddressAffectAntigensApplied ResearchBacteriaBacterial PneumoniaBasic ScienceBehaviorBiologyBurn TraumaCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCellsChronicClinicalComplexCritical IllnessDataDiseaseEquilibriumGoalsHealthHomeostasisImmuneImmune responseImmune systemImmunityImmunologyImmunotherapyInfectionInflammationInflammatoryInjuryKnowledgeLifeModelingMolecularMolecular ProfilingMusNatureOpportunistic InfectionsOrganOutcomeOutcomes ResearchPatientsPatternPeripheralPhenotypeProcessPublishingRegulatory T-LymphocyteReportingResearchSeriesSpecificityStimulusSystemic Inflammatory Response SyndromeT-Cell ReceptorT-LymphocyteTestingTherapeuticTissuesTraumaTraumatic injuryantimicrobialbasecell typecytokineexperimental studyimmune functionimmunoreactionimmunoregulationimprovedinjuredinsightinterestnovelpost-traumaresponserestorationsevere injurytissue injury
中文摘要
项目摘要
创伤性损伤破坏了免疫系统的稳态,这可能使患者容易发生机会性免疫缺陷。
感染和其他创伤相关并发症,如全身炎症反应综合征(SIRS),
器官损伤和慢性危重病。创伤诱导独特而复杂的宿主反应,
由组织损伤和释放引发炎症的炎症相关分子模式(DAMP)引发
特异性免疫反应。我们发现,一个称为调节性T细胞(Treg)的CD 4 + T细胞亚群,
在小鼠烧伤创伤模型中被损伤急性激活。抗炎抑制活性的
创伤可增强TdR,这表明TdR可能控制创伤后炎症的强度
和恢复免疫系统的稳态。人们的组织中可能有不同数量的TbR,
对创伤有不同的功能性Treg反应,这可以决定他们对创伤反应的轨迹,
外伤我们的假设是,TdR控制对DAMP的免疫反应,并影响免疫应答。
宿主对创伤的反应轨迹为了解决这个假设,我们提出了一系列的创伤
免疫学研究以系统地询问; 1)免疫系统表型的Treg控制,
体内平衡,2)创伤诱导的Treg活化机制,和3)调节Treg对免疫调节的作用。
表型、抗微生物免疫功能和两次打击SIRS反应。本项目的具体目标
1)为了确定CD 4 + T细胞如何控制免疫系统对创伤的反应性,2)为了确定CD 4 + T细胞的特异性,
创伤反应性CD 4 + T细胞和其他T细胞的分子性质,3)为了研究CD 4 + T细胞在创伤中的作用,
影响抗微生物免疫和二次感染SIRS。我们预计,这项研究的结果将
显著地推进了我们对调节创伤特异性免疫机制的基础知识
免疫力我们有几个重要的目标,我们希望在这个项目的过程中实现:1)
为Treg激活和功能的生物学提供新的见解,2)更深入地了解
哺乳动物创伤反应的免疫系统控制,以及3)探索
调节Treg活化和功能作为特异性创伤免疫疗法以改善免疫功能,
创伤后的平衡
英文摘要
PROJECT SUMMARY
Traumatic injuries disrupt immune system homeostasis, which can predispose patients to opportunistic
infections and other trauma-associated complications like systemic inflammatory response syndrome (SIRS),
organ damage, and chronic critical illnesses. Trauma induces unique and complex host responses that are
initiated by tissue damage and the release of danger-associated molecular patterns (DAMPs) that trigger
specific immune reactions. We identified that a subset of CD4+ T cells called regulatory T cells (Tregs) are
acutely activated by injury in a mouse burn trauma model. The counter-inflammatory suppressive activity of
Tregs is enhanced by trauma, which suggests that Tregs may control the intensity of post-trauma inflammation
and restoration of immune system homeostasis. People can have different numbers of Tregs in their tissues or
have different functional Treg responses to trauma that could determine trajectory of their response to
traumatic injuries. Our hypothesis is that Tregs control immune reactions to DAMPs and influence the
trajectory of the host response to trauma. To address this hypothesis, we propose a series of trauma
immunology studies to systematically interrogate; 1) Treg control of immune system phenotypes and
homeostasis, 2) trauma-induced Treg activation mechanisms, and 3) effects of modulating Tregs on immune
phenotypes, anti-microbial immune function, and the two-hit SIRS response. The specific aims for this project
are; 1) To determine how CD4+ Tregs control immune system reactivity to trauma, 2) To define the specificity
and molecular nature of trauma-reactive CD4+ Tregs and other T cells, 3) To investigate how CD4+ Tregs
influence anti-microbial immunity and two-hit SIRS. We anticipate that the outcome of this research will
significantly advance our fundamental knowledge of specific immune mechanisms that modulate trauma
immunity. We have several significant goals that we wish to achieve during the course of this project; 1) to
provide new insights into the biology of Treg activation and function, 2) to develop a deeper understanding of
immune system control of the mammalian trauma response, and 3) to explore the therapeutic potential of
modulating Treg activation and function as a specific trauma immunotherapy to improve immune function and
balance following trauma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Trained Immunity in Trauma-Induced Immune Dysregulation
-
批准号:10714384
-
项目类别:
-
资助金额:$51.05万
-
财政年份:2023
-
负责人:JAMES A. LEDERER
-
依托单位:
Adaptive Immune Regulation of Traumatic Injury
-
批准号:10415072
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2020
-
负责人:JAMES A. LEDERER
-
依托单位:
Adaptive Immune Regulation of Traumatic Injury
-
批准号:10624318
-
项目类别:
-
资助金额:$41.46万
-
财政年份:2020
-
负责人:JAMES A. LEDERER
-
依托单位:
Therapy of acute radiation syndrome and its complications by mesenchymal stromal cells conditioned with Toll-like receptor 9 agonists
-
批准号:9899920
-
项目类别:
-
资助金额:$58.23万
-
财政年份:2018
-
负责人:JAMES A. LEDERER
-
依托单位:
Therapy of acute radiation syndrome and its complications by mesenchymal stromal cells conditioned with Toll-like receptor 9 agonists
-
批准号:10374106
-
项目类别:
-
资助金额:$58.23万
-
财政年份:2018
-
负责人:JAMES A. LEDERER
-
依托单位:
Cellular Systems Core
-
批准号:10454989
-
项目类别:
-
资助金额:$26.71万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Cellular Systems Core
-
批准号:10281359
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Single Cell and Immunoanalysis Core
-
批准号:10455094
-
项目类别:
-
资助金额:$14.11万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Single Cell and Immunoanalysis Core
-
批准号:10615219
-
项目类别:
-
资助金额:$14.11万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Cellular Systems Core
-
批准号:10684886
-
项目类别:
-
资助金额:$26.71万
-
财政年份:2016
-
负责人:JAMES A. LEDERER
-
依托单位:
Restoring Immune Function Following Radiation Injuries by TLR9 Agonist Treatment
-
批准号:8660290
-
项目类别:
-
资助金额:$65.95万
-
财政年份:2013
-
负责人:JAMES A. LEDERER
-
依托单位:
Restoring Immune Function Following Radiation Injuries by TLR9 Agonist Treatment
-
批准号:8573161
-
项目类别:
-
资助金额:$58.43万
-
财政年份:2013
-
负责人:JAMES A. LEDERER
-
依托单位:
Injury-Specific Activation of the Immune System
-
批准号:8115690
-
项目类别:
-
资助金额:$41.45万
-
财政年份:2011
-
负责人:JAMES A. LEDERER
-
依托单位:
Injury-Specific Activation of the Immune System
-
批准号:8665375
-
项目类别:
-
资助金额:$41.48万
-
财政年份:2011
-
负责人:JAMES A. LEDERER
-
依托单位:
Injury-Specific Activation of the Immune System
-
批准号:8281415
-
项目类别:
-
资助金额:$41.48万
-
财政年份:2011
-
负责人:JAMES A. LEDERER
-
依托单位:
Injury-Specific Activation of the Immune System
-
批准号:8468920
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2011
-
负责人:JAMES A. LEDERER
-
依托单位:
Immunological Complications of Radiation Combined Injury
-
批准号:7898011
-
项目类别:
-
资助金额:$9.97万
-
财政年份:2009
-
负责人:JAMES A. LEDERER
-
依托单位:
Immunological Complications of Radiation Combined Injury
-
批准号:8127884
-
项目类别:
-
资助金额:$59.54万
-
财政年份:2008
-
负责人:JAMES A. LEDERER
-
依托单位:
Immunological Complications of Radiation Combined Injury
-
批准号:7560141
-
项目类别:
-
资助金额:$25.06万
-
财政年份:2008
-
负责人:JAMES A. LEDERER
-
依托单位:
Immunological Complications of Radiation Combined Injury
-
批准号:7649465
-
项目类别:
-
资助金额:$16.87万
-
财政年份:2008
-
负责人:JAMES A. LEDERER
-
依托单位:
海外基金